Current Research

Every study SARRC conducts is valuable to the autism community, but we cannot do it alone. We look to families of individuals impacted by autism to participate in our current research projects.

Current Research Projects 

SARRC's research brings together methods and scientists in an effort to gain greater understanding of possible causes of autism, identify better treatments, and learn, as well as educate others, about how to improve the quality of life for those affected by ASD and their families.

View all current studies below:

Janssen Study

The Janssen study is currently enrolling adolescents and adults (age 13-30) with an autism diagnosis to help determine if an investigational medicine is useful in treating individuals with ASD. Participation in the trial includes eight visits to SARRC over the course of 16 weeks. 

» Learn more here or for more information, contact us at 602.218.8183.

Zynerba Study

This study is currently enrolling children and adolescents to measure the effectiveness and safety of Cannabidiol gel in helping children with their symptoms of Fragile X Syndrome. The study is enrolling children and adolescents with Fragile X syndrome ages 3 to <18. 

» Learn more here or for more information, contact us at 602.218.8183.

Early Eye Tracking Study

SARRC is leading an investigational device clinical trial in partnership with Marcus Autism Center, part of Children’s Healthcare of Atlanta. This study will examine the early development of basic social skills in young children. We will observe how children who have autism and other developmental delays and those who are typically developing attend to their social environment. This research could lead to the development of new methods of diagnosing ASD in toddlers.

We are seeking toddlers who are 16 to 30 months old to take part in the study at SARRC. Whether or not your family has concerns about autism or other developmental delays in your child, he or she can participate in our study.

» Learn more here or for more information, contact us at 602.218.8183.


SPARK is the largest genetic study of autism to date and seeks to expand the scope of autism research. Our team is looking for individuals of all ages with a diagnosis of ASD to become part of this nationwide initiative. Biological parents and full biological siblings (with and without ASD) are invited to participate as well. There’s no cost to register, and compensation is valued at up to $50. Saliva samples are required (no needles, no blood draws). SPARK is an ongoing study with multiple participation options available, including home visits from one of our research coordinators or mail-order kits.

» Contact Kendra Coleman at to schedule a home visit, have the kit mailed to your home, or set up an appointment at one of our campuses.

OVID Study (Rocket Study)

This study will evaluate the safety and tolerability of an investigational medication which may help individuals with Fragile X Syndrome. The study is enrolling male participants with Fragile X Syndrome ages 13-22.  

» Learn more here or for more information, contact us at 602.218.8183.

ASD Screening Project

SARRC collaborates with more than 100 pediatricians to reduce the age of autism screening and detection. Pediatricians participating in our network screen children for developmental delays at 12-, 18-, and 24-month check-ups, and refer families whose children have scores that indicate a potential developmental delay to SARRC for a developmental evaluation.

» Learn more here. To see if your pediatrician is in our network, contact us at 602.218.8187.

Aviation Study

The aim of this study is to investigate the safety and efficacy of a drug designed to help with sociability. 

» Learn more here or to register, contact us at 602.218.8199. 

ASD and Aging (fMRI Study)

Do you experience subtle social differences? SARRC and Barrow Neurological Institute are investigating the aging process of the brain in individuals with ASD when compared to typically developing peers with the use of fMRI scans. 

Right-handed males ages 18-25, and 40+. For more details, click here.
Right-handed females ages 18-25, and 40+. For more details, click here.

» To register, contact us at 602.218.8199. 

Orbiting Study

This observational study will test the reliability of smartphone technologies and in-person assessments in measuring repetitive and restricted behaviors in individuals with autism. Study is enrolling for ages 5 to 45. 

» For more information or to enroll, contact us at 602.218.8199.


This study will evaluate a remote diagnostic procedure, with hopes of improving accessibility to diagnostic evaluations for children ages 18 months to 6 years. En espanol: Dignostico del autismo – obtenga respuestas rapidamente.

» For more information or to enroll, contact (se habla espanol) us at 602.218.8184.

Transition Into Adulthood: Skills Study

This study is for adolescents and adults with autism and involves a visit to SARRC’s campus where participants will complete assessments and participate in an interview about transition-related experiences with a member of our clinical team. Responses from these interviews will be used to inform the development of a new intervention for youth with autism.

» Learn more here or to learn more, contact us at 602.218.8184.

Nearly all of our active studies provide compensation or travel reimbursement for families! Learn more by contacting our team.